The 2024 Medical Laboratory Observer (MLO) State of the Industry (SOI) survey on molecular diagnostics (MDx) queried medical laboratory professionals on MDx testing trends, including types of testing modalities used in their labs, methods for handling quality issues, and volume of respiratory testing compared with last year.
More than four years out from the height of the COVID-19 pandemic, we eliminated COVID-19 specific testing questions, although we continued to ask lab professionals about supply shortages given continued disruptions in the healthcare supply chain.
New for this year, the survey questioned lab professionals about their development of tools/processes to manage decreased access to laboratory developed tests (LDT).
Download now to learn more.
This content is sponsored by:
